Szpital Specjalistyczny Nr 1; Oddzial Reumatologii I Rehabilitacji
About Szpital Specjalistyczny Nr 1; Oddzial Reumatologii I Rehabilitacji
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Szpital Specjalistyczny Nr 1; Oddzial Reumatologii I Rehabilitacji
During the past decade, Szpital Specjalistyczny Nr 1; Oddzial Reumatologii I Rehabilitacji conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects
2010-04-01
2012-01-01
Completed
26
Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study)
2011-09-01
2015-05-01
Completed
54
Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)
2014-02-20
2021-12-23
Completed
85
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
2016-09-09
2020-12-15
Completed
681
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
2017-03-24
2024-08-15
Active, not recruiting
1,239
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
2018-06-06
2023-02-17
Terminated
1,054
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
2020-11-26
2029-03-30
Recruiting
865
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Szpital Specjalistyczny Nr 1; Oddzial Reumatologii I Rehabilitacji
According to Clinical.Site data, the most researched conditions in "Szpital Specjalistyczny Nr 1; Oddzial Reumatologii I Rehabilitacji" are
"Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Szpital Specjalistyczny Nr 1; Oddzial Reumatologii I Rehabilitacji" in a lesser frequency.
Clinical Trials Intervention Types at Szpital Specjalistyczny Nr 1; Oddzial Reumatologii I Rehabilitacji
Most popular intervention types in "Szpital Specjalistyczny Nr 1; Oddzial Reumatologii I Rehabilitacji" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Methotrexate" (1 trials), "Placebo" (1 trials), "Placebo to methotrexate" (1 trials), "Placebo to tocilizumab" (1 trials) and "Rob 803" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Szpital Specjalistyczny Nr 1; Oddzial Reumatologii I Rehabilitacji
The vast majority of trials in "Szpital Specjalistyczny Nr 1; Oddzial Reumatologii I Rehabilitacji" are
2 trials for "All" genders.
Clinical Trials Status at Szpital Specjalistyczny Nr 1; Oddzial Reumatologii I Rehabilitacji
Currently, there are NaN active trials in "Szpital Specjalistyczny Nr 1; Oddzial Reumatologii I Rehabilitacji".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Szpital Specjalistyczny Nr 1; Oddzial Reumatologii I Rehabilitacji,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Szpital Specjalistyczny Nr 1; Oddzial Reumatologii I Rehabilitacji, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".